Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nursing Clinical Information System01:27

Nursing Clinical Information System

1.3K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.3K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.5K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.5K
Current Trends in Nursing II01:30

Current Trends in Nursing II

3.6K
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
3.6K
Clinical Trials01:16

Clinical Trials

11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.0K
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

203
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
203

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Joint Clinical Assessments in Europe: Implications for Market Access, Reimbursement, and National HTA Alignment.

Pharmaceutical medicine·2025
Same author

Importance of Health Economics and Outcomes Research in the Product Lifecycle.

Pharmaceutical medicine·2025
Same author

Extent of use of artificial intelligence & machine learning protocols in cancer diagnosis: A scoping review.

The Indian journal of medical research·2023
Same author

Real-World Evidence: A Primer.

Pharmaceutical medicine·2023
Same author

Nature and mechanism of immune boosting by Ayurvedic medicine: A systematic review of randomized controlled trials.

World journal of methodology·2022
Same author

Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review.

Drug safety·2021

Related Experiment Video

Updated: Mar 12, 2026

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

3.1K

Real world evidence: An Indian perspective.

Amit Dang1, B N Vallish2

  • 1MarksMan Healthcare Solutions LLP, Kopar Khairane, Navi Mumbai, Maharashtra, India.

Perspectives in Clinical Research
|November 16, 2016
PubMed
Summary

Real-world evidence (RWE) complements traditional randomized controlled trials (RCTs) by using real-world data (RWD) to assess drug safety and efficacy. India is developing a framework to harmonize RWD for better healthcare decisions.

Keywords:
Clinical outcomehealth economicshealth technology assessmenthumanistic outcomereal world datareal world evidence

More Related Videos

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.6K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

13.7K

Related Experiment Videos

Last Updated: Mar 12, 2026

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
09:33

Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India

Published on: December 23, 2022

3.1K
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

1.6K
A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

13.7K

Area of Science:

  • Health Economics and Outcomes Research
  • Clinical Trial Design
  • Pharmacovigilance

Background:

  • Randomized controlled trials (RCTs) are the benchmark for drug evaluation but face increasing scrutiny from payers and providers seeking real-world evidence (RWE).
  • Real-world data (RWD) from diverse sources like electronic health records and registries are crucial for validating drug effectiveness and safety in routine clinical practice.
  • The global shift towards RWE necessitates its adoption in healthcare markets for robust decision-making.

Approach:

  • This work explores the growing importance of RWE in healthcare, contrasting it with traditional RCT methodologies.
  • It highlights the various sources of RWD that can be leveraged to generate meaningful insights.
  • The adoption of RWE approaches in developed nations is discussed as a precedent for other healthcare systems.

Key Points:

  • RWE provides valuable insights into drug performance and patient outcomes beyond controlled trial settings.
  • Diverse RWD sources, including administrative data and electronic health records, are essential for comprehensive RWE generation.
  • RWE is increasingly integral to market access and clinical practice validation for new medical interventions.

Conclusions:

  • The Indian healthcare sector is adopting health economics and outcomes research principles, recognizing the value of RWE.
  • India is establishing a framework to harmonize RWD, aiming to improve economic, clinical, and humanistic outcomes.
  • The integration of RWE is pivotal for informed healthcare decision-making and demonstrating the value of medical products in India.